Monitor the shareholder vote on the Fortitude Mining merger — the CEO's 7.5% stake and insider alignment are relevant to deal approval odds. The FDA clearance is a positive standalone catalyst but is being subsumed by the crypto pivot.
Price Chart
Executive Summary
CEO Andrew Simpson filed an amended Schedule 13D disclosing unchanged beneficial ownership of 403,739 shares (7.5% of common stock on a converted basis) following FDA 510(k) clearance of the MyoVista wavECG device. The filing is a routine ownership update triggered by the FDA milestone and accelerated option vesting, with no change in position or activist demands. The filing coincides with the company's pending all-stock merger with Fortitude Mining Holdings, Inc., a Zcash-focused crypto mining platform, which is the subject of active proxy solicitation.
Key Financial Metrics
Key Facts
- CEO Andrew Simpson directly beneficially owns 403,739 shares of common stock, representing 7.5% on a converted basis as of October 8, 2026.
- FDA 510(k) clearance of MyoVista wavECG device on October 5, 2026 triggered accelerated vesting of all CEO options (323,833 shares).
- No open-market purchases or sales by the CEO in the last 60 days.
- The filing is an amendment to Schedule 13D, not a new activist position — the CEO is filing as an insider, not an activist.
- The company is pursuing an all-stock merger with Fortitude Mining Holdings, Inc., a Zcash-focused digital asset mining platform, with a special meeting to vote on the transaction.
Financial Impact
No new financial impact — CEO stake unchanged at 7.5% of common stock on a converted basis.
Risk Factors
- Pending merger with Fortitude Mining represents a transformative shift from medtech to crypto mining, creating execution and valuation risk.
- CEO's stake is largely in unexercised options and unvested restricted shares tied to the merger closing, creating alignment but also potential overhang if the deal fails.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13D/A Filing (Primary) | 0001213900-26-112224 |
| Document: 0001213900-26-112224-index.html | 0001213900-26-112224 |
| Document: 0001213900-26-112224.txt | 0001213900-26-112224 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | DEFA14A | $3.18 | awaiting T+1 | — | $3.28 (+3.14%) |
Oct 26, 2026 1d ago | DEFA14A | $3.14 | awaiting T+1 | — | $3.28 (+4.46%) |
Oct 23, 2026 3d ago | SC 13D/A | $3.41 | awaiting T+1 | — | $3.28 (−3.81%) |
Oct 21, 2026 5d ago | DEFA14A | $3.17 $3.14 | ▼ −0.95% | ▼ −0.42% | $3.28 (+3.47%) |
Oct 19, 2026 7d ago | DEFA14A | $3.13 $3.56 | ▲ +13.74% | ▲ +13.21% | $3.28 (+4.79%) |
Oct 19, 2026 8d ago | DEFA14A | $3.07 $3.13 | ▲ +1.95% | ▲ +1.62% | $3.28 (+6.84%) |
Oct 19, 2026 8d ago | DEFM14A | $3.07 $3.13 | ▼ −1.95% | ▼ −1.62% | $3.28 (−6.84%) |
Oct 15, 2026 11d ago | DEFA14A | $3.02 $3.07 | ▲ +1.66% | ▲ +1.23% | $3.28 (+8.61%) |
Oct 9, 2026 17d ago | 424B5 | $3.30 $3.09 | ▲ +6.36% | ▲ +6.35% | $3.28 (+0.61%) |
Oct 6, 2026 20d ago | DEFA14A | $3.49 $3.04 | ▼ −12.89% | ▼ −12.47% | $3.28 (−6.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers